Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Cash from Operations (2020 - 2025)

BioAtla (BCAB) has disclosed Cash from Operations for 6 consecutive years, with 7915000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Operations rose 52.84% year-over-year to 7915000.0; the TTM value through Dec 2025 reached 48204000.0, up 32.99%, while the annual FY2025 figure was 48204000.0, 32.99% up from the prior year.
  • Cash from Operations hit 7915000.0 in Q4 2025 for BioAtla, up from 9881000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 5132000.0 in Q3 2024 and bottomed at 30828000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 18839450.0, with a median of 18057000.0 recorded in 2022.
  • Year-over-year, Cash from Operations plummeted 343.81% in 2021 and then soared 81.23% in 2024.
  • BioAtla's Cash from Operations stood at 20949000.0 in 2021, then fell by 16.22% to 24347000.0 in 2022, then fell by 22.9% to 29922000.0 in 2023, then skyrocketed by 43.91% to 16783000.0 in 2024, then soared by 52.84% to 7915000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 7915000.0, 9881000.0, and 14120000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.